EL PASO, Texas--(BUSINESS WIRE)--Premier Biomedical, Inc. (OTCQB: “BIEI”) announced the addition of Dr. James Frincke to their Scientific Advisory Board effective immediately. Dr. Frincke will report to co-founder and Chairman of the Scientific Advisory Board, Dr. Mitchell S. Felder, MD, and to the President and CEO, William A. Hartman.
James Frincke, PhD, is a Research & Development Consultant at Red Spot Biosciences, LLC, currently providing pro bono consultation to physicians globally to discover treatments for diseases, such as Crohn’s, Rheumatoid Arthritis, Alzheimer’s, Parkinson’s and Type 1 Diabetes.
Help employers find you! Check out all the jobs and post your resume.
